Evidence map›Paper›PMID 41728092›Full record

ArticleFrontiers in aging neuroscience2026

IL1A enhances TNF-induced retinal ganglion cell death.

Katherine M Andersh, Michael MacLean, Gareth R Howell, Richard T Libby

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Katherine M Andersh *Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States.
Michael MacLean *The Jackson Laboratory, Bar Harbor, ME, United States.
Gareth R HowellThe Jackson Laboratory, Bar Harbor, ME, United States.
Richard T LibbyDepartment of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States.

Funding

VISUAL SCIENCET32EY007125 · NEI · UNIVERSITY OF ROCHESTER · PI Krystel R Huxlin, Duje Tadin · 1990 to 2026
$7.1M
Cell Death Pathways in Glaucomatous NeurodegenerationR01EY018606 · NEI · UNIVERSITY OF ROCHESTER · PI JOHN, SIMON W, LIBBY, RICHARD T · 2008 to 2023
$5.8M
Dissecting the complex role of microglia states in glaucomaR01EY035093 · NEI · UNIVERSITY OF ROCHESTER · PI Gareth R Howell, Richard T Libby · 2023 to 2026
$2.6M
NEI NIH HHS R01 EY018606NEI NIH HHS R01 EY035093NEI NIH HHS T32 EY007125
6 · The paper itself

Abstract

Introduction: A growing body of literature suggests a role for neuroinflammation in retinal ganglion cell (RGC) death in glaucoma. For instance, deficiency of three proinflammatory cytokines, complement component 1, subcomponent q ( Methods: Eyes of 2-4 month-old C57BL/6J mice or mice deficient in either Results: Intravitreal injection of IL1A did not result in RGC death at either 14 days or 12 weeks. Consistent with previous studies, TNF injection did not cause significant RGC loss at 14 days but did after 12 weeks. Together, IL1A+TNF resulted in a relatively rapid RGC death, driving significant loss 2 weeks after injection. We identified molecular changes which occur in response to IL1A and to combined IL1A+TNF treatment with limited changes identified in TNF alone treated eyes. Using mice deficient in Discussion: We identified a novel role of IL1A, we found that IL1A acted as a sensitizer to TNF-induced death. Co-injection of IL1A and TNF resulted in rapid RGC death, with significant RGC loss 14 days after injection. TNF+IL1A-induced RGC death did not depend on JUN activation and was rather SARM1 dependent. Also, RNA-seq analyses indicated that while

Indexed as

glaucomainterleukin 1neuroinflammationopticneuropathyproinflammatory cytokines

Identifiers

PMID41728092
PMCPMC12917762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.